Dr. Sreekumar Raghavakaimal's laboratory work at the Mayo Clinic positioned him at the forefront of research linking mitochondrial biology, proteomics, and aging — helping answer fundamental questions about why people develop insulin resistance as they age.
The Science of Aging and Metabolic Decline
One of the defining scientific questions of our era is why the human body becomes more susceptible to metabolic disease with age. At Mayo Clinic, Dr. Raghavakaimal's core laboratories provided the technological backbone for studies exploring this question at the molecular level.
Using Affymetrix microarray platforms, tandem mass spectrometry, and stable isotope tracer technology, Dr. Raghavakaimal and his collaborators measured protein synthesis rates in skeletal muscle, identified differentially expressed genes in diabetic vs. non-diabetic tissues, and characterized mitochondrial dysfunction as a key driver of age-related insulin resistance.
A particularly significant body of work emerged from collaboration with Dr. K. Sreekumaran Nair's group — demonstrating that reduced mitochondrial protein synthesis is a hallmark of aging, and that exercise can meaningfully counteract this decline, offering a molecular rationale for physical activity as medicine.
Research Milestones
Mitochondrial Aging
Identified reduced mitochondrial protein synthesis as a molecular signature of aging in skeletal muscle, linking gene expression to metabolic decline.
Exercise as Medicine
Co-authored landmark Diabetes (2008) study showing endurance exercise reverses age-related mitochondrial decline — a finding with direct clinical implications.
Population Differences
Demonstrated that Asian Indians exhibit elevated skeletal muscle mitochondrial ATP production in association with severe insulin resistance — a paradigm-shifting population finding.
Diabetes & Aging Research Papers
Exercise as a Countermeasure for Aging. Ian R. Lanza, Daniel K. Short, Yan W. Asmann, Sreekumar Raghavakaimal, et al. Diabetes, 57, 2933 (2008).
View publication →Asian Indians Have Enhanced Skeletal Muscle Mitochondrial Capacity to Produce ATP in Association with Severe Insulin Resistance. K. S. Nair, M. L. Bigelow, Y. W. Asmann, L. S. Chow, J. M. Schimke, K. A. Klaus, Z. K. Guo, Sreekumar Raghavakaimal, B. A. Irving. Diabetes, 57, 1166 (2008).
View publication →Additional publications on diabetes, aging, and metabolic research are listed in the full publications list.
Questions About This Research
What is Dr. Sreekumar Raghavakaimal's contribution to diabetes research?
Dr. Raghavakaimal contributed pivotal proteomics and genomics support to diabetes research at Mayo Clinic. His work helped identify mitochondrial dysfunction as a key driver of insulin resistance, and his co-authored Diabetes 2008 papers are among the most significant publications in metabolic aging research.
How did Dr. Sreekumar Raghavakaimal study aging at the molecular level?
Using microarray gene expression analysis, tandem mass spectrometry, and stable isotope tracers, Dr. Raghavakaimal's laboratories mapped changes in mitochondrial protein synthesis rates and gene expression during aging — providing a molecular-level understanding of metabolic decline.
What journals published his diabetes and aging research?
His diabetes and aging research appeared in Diabetes, the American Journal of Physiology, Mechanisms of Ageing and Development, and other leading peer-reviewed scientific journals.
Explore More Research
Read about Dr. Raghavakaimal's full body of work across all research areas.